Institutional Review Boards, a System in Jeopardy: Hearing Before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, Second Session, June 11, 1998 |
From inside the book
Results 1-5 of 49
Page 14
... understanding of ( 1 ) the challenges facing IRBs and ( 2 ) how the IRBs and the Federal government were meeting these challenges . Toward that end , we developed a multi - faceted methodology drawing on many sources . These included ...
... understanding of ( 1 ) the challenges facing IRBs and ( 2 ) how the IRBs and the Federal government were meeting these challenges . Toward that end , we developed a multi - faceted methodology drawing on many sources . These included ...
Page 16
... understand the distinction between research and treatment . Resources Subcommittee June 11 , 1998 2. IRBS Conduct Minimal Continuing Review of Approved Research . House Government Reform and Oversight Committee Page 5 16.
... understand the distinction between research and treatment . Resources Subcommittee June 11 , 1998 2. IRBS Conduct Minimal Continuing Review of Approved Research . House Government Reform and Oversight Committee Page 5 16.
Page 17
... understand the implications of their decision to participate . The 1995 Advisory Commission on Human Radiation ... understanding of the informed consent forms they signed . However , continuing review has become a low priority at many ...
... understand the implications of their decision to participate . The 1995 Advisory Commission on Human Radiation ... understanding of the informed consent forms they signed . However , continuing review has become a low priority at many ...
Page 21
... understand what they are consenting to when they agree to participate in a research effort . Yet , FDA's inspection process does not extend beyond determining that informed consent forms contain all the appropriate elements and that ...
... understand what they are consenting to when they agree to participate in a research effort . Yet , FDA's inspection process does not extend beyond determining that informed consent forms contain all the appropriate elements and that ...
Page 22
... understanding of these issues is also essential for research investigators who , themselves , initiate the informed consent process and interact directly with research subjects . Nationally , in the context of the numbers of research ...
... understanding of these issues is also essential for research investigators who , themselves , initiate the informed consent process and interact directly with research subjects . Nationally , in the context of the numbers of research ...
Other editions - View all
Common terms and phrases
agencies approved assurance behavior Belmont Report benefits Biological Psychiatry biomedical Center Chairman Christopher Shays clinical research clinical trials Committee concerns conducted consent form continuing review Department of Health disorders drug ELLIS ensure ethical evaluate Federal regulations fenfluramine fenfluramine study funds Gary Ellis Government Reform GROB haloperidol Health and Human HIMA Human Services human subject protection human subjects research informed consent document informed consent process Inspector Institutional Review Boards IRB members IRB review IRB system IRB's issues June 11 Kammen DP Levine Meslin methylphenidate monitoring NBAC NIH-GRANT-NUMBER NIH/OPRR NIMH Office OIG's OPRR patients pharmaceutical population potential problems procedures Protection from Research protection of human Psychiatric Institute question recommendations regulatory research involving research protocols Research Risks research subjects response rights and welfare schizophrenia serotonin SHAYS SNOWBARGER sponsors staff Subcommittee system of protection Thank Timothy Walsh Towns understand volunteer WALSH YESSIAN
Popular passages
Page 46 - A description of any benefits to the subject or to others which may reasonably be expected from the research; §27.114 §27.116 (4) A disclosure of appropriate alternative procedures or courses of treatment, if any, that might be advantageous to the subject; (5) A statement describing the extent, if any, to which confidentiality of records identifying the subject will be maintained...
Page 47 - ... injury occurs and, if so, what they consist of, or where further information may be obtained 7. An explanation of whom to contact for answers to pertinent questions about the research and research subjects' rights, and whom to contact in the event of a research-related injury to the subject 8.
Page 47 - A statement describing the extent, if any, to which confidentiality of records identifying the subject will be maintained; (6) For research involving more than minimal risk, an explanation as to whether any compensation and an explanation as to whether any medical treatments are available if injury occurs and, if so, what they consist of, or where further information may be obtained; (7) An explanation of whom to contact for answers to pertinent questions about the research and research subjects'...
Page 45 - When some or all of the subjects are likely to be vulnerable to coercion or undue influence, such as children, prisoners, pregnant women, mentally disabled persons, or economically or educationally disadvantaged persons, additional safeguards have been included in the study to protect the rights and welfare of these subjects.
Page 48 - Department of Agriculture Department of Commerce Department of Defense Department of Education Department of Energy Department of Health and Human Services Department of Housing and Urban Development...
Page 110 - New imaging techniques, such as positron emission tomography (PET) and functional magnetic resonance imaging (fMRI), promise advances in our ability to identify regions of the brain associated with cognitive and affective disorders.
Page 131 - This meeting is adjourned. [Whereupon, at 3:35 pm, the subcommittee was adjourned, to reconvene at the call of the Chair.] [Additional information submitted for the hearing record follows:] EXECUTIVE OFFICE OF THE PRESIDENT OFFICE OF MANAGEMENT AND BUDGET WASHINGTON.
Page 6 - ... opening statement in the record, and that the record remain open for 3 days for that purpose. Without objection, so ordered. I ask further unanimous consent that all witnesses be permitted to include their written statements in the record.
Page 46 - ... are experimental. (2) A description of any reasonably foreseeable risks or discomforts to the subject. (3) A description of any benefits to the subject or to others which may reasonably be expected from the research. (4) A disclosure of appropriate alternative procedures or courses of treatment, if any, that might be advantageous to the subject. (5) A statement describing the extent, if any, to which confidentiality of records identifying the subject will be maintained and that notes the possibility...
Page 143 - The intervention or procedure is likely to yield generalizable knowledge about the subjects' disorder or condition which is of vital importance for the understanding or amelioration of the subjects...